Cresanto Global Limited (formerly Raymed Labs Limited) has approved material related party transactions involving its four promoter directors, capping exposure at ₹5 crore per individual. The Board of Directors sanctioned these arrangements during a meeting held in Mumbai on July 31, 2026, establishing a framework for future business dealings with key stakeholders through the end of the current fiscal cycle.

The approval covers transactions entered into in the normal course of business, including contracts, loans, and corporate guarantees. These deals are structured to align with terms and conditions generally prevalent in the industry segments where Cresanto operates. The authorization remains valid from the conclusion of the Annual General Meeting (AGM) held in FY26-27 until the AGM scheduled for FY27-28.

Transaction Details

The Board approved specific monetary limits for each related party. The transactions are subject to a maximum value as outlined below:

Regulatory Compliance

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. The transactions also fall under Section 188 of the Companies Act, 2013, and Regulation 23 of the SEBI LODR Regulations, 2015.

The related parties are identified under Section 2(76) of the Companies Act and Regulation 2(1)(zb) of the SEBI Listing Regulations due to their significant influence over the reporting entity. Managing Director Prashant Nathmal Bajaj signed the disclosure, confirming the Board's ratification of these material agreements.

Cresanto Global Limited shareholders have approved proposals to change the company name and shift its registered office from Uttar Pradesh to Maharashtra. The resolutions were passed through a postal ballot process conducted via remote e-voting, with results declared on June 3, 2026. These changes require consequential amendments to the Memorandum of Association and Articles of Association.

The postal ballot sought shareholder approval for three special resolutions. The first resolution covered the change of name and the associated amendments to the company's constitutional documents. The second resolution authorized the shifting of the registered office from Uttar Pradesh to Maharashtra. The third resolution addressed the alteration of the registered office clause in the Memorandum of Association.

Sachin Singh & Associates, Practicing Company Secretaries, were appointed as the scrutinizer for the process. The remote e-voting facility was provided by National Securities Depository Limited (NSDL). The cut-off date for determining eligible shareholders was April 24, 2026. The remote e-voting period commenced on May 5, 2026, and concluded on June 3, 2026.

The following table summarizes the voting results for the resolutions:

Cresanto Global Limited, formerly known as Raymed Labs Limited, is currently headquartered in Mumbai, Maharashtra, while its registered office is in Noida, Uttar Pradesh. The process was conducted in accordance with Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Companies Act, 2013.